The effect of USP10 in prostate cancer is via its modulation of the p53-G3BP2 complex and androgen receptor signaling; USP10 associates with and increases the stability of G3BP2 by reducing polyubiquitination. This evidence concerns the gene AR and prostate carcinoma.